iNTApharma provides fast, label‑free nanoparticle characterization for teams working on gene and cell therapy vectors, extracellular vesicles, and next‑generation delivery systems—offering immediate insights into critical quality attributes (CQAs) across AdV, EV, LNP, and more.
Enhanced Data Depth
Increased Workflow Efficiency
Sample Conservation
Operational Flexibility
The 18-wellplate consumeable makes your life easier.
Fill consumeable in biosafety cabinet and seal it.
Place consumeable on instrument and start analysis.
Assess Critical Quality Attributes
Easy disposal of consumeable after "autoclaving" it for 30 min.
Label-Free Discrimination of Extracellular Vesicles (EV)
This application note details how Interferometric Nanoparticle Tracking Analysis (iNTA) provides high-resolution, label-free quality control for adenoviral vectors (AdV). It is essential for researchers needing to distinguish intact viruses from contaminants or empty capsids, a task challenging for conventional methods like DLS or NTA.
Quality Assessment of Adenoviral Vectors
This application note highlights how Interferometric Nanoparticle Tracking Analysis (iNTA) achieves label-free discrimination of extracellular vesicles (EVs) from co-isolates like lipoproteins in complex biological fluids. It is a vital read for researchers seeking to bypass the limitations of traditional size-based separation and fluorescence labeling.
Directly talk to our application experts and learn how iNTA can support your work.